Close Menu

NEW YORK – EliTech Group announced Tuesday its SARS-CoV-2 Plus Elite MGB Kit received CE marking and has been launched.

The kit detects and distinguishes between SARS-CoV-2, influenza A/B, and respiratory syncytial virus types A and B, the company said in a statement. It runs on the firm's Elite InGenius platform, as well as other major PCR thermocyclers. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.